Antares Therapeutics

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://antaresrx.com/

Last Round

Corporate Funding

Jun 24, 2026

Total Funding Raised

$177M

Company Overview

Antares Therapeutics is a biotechnology company that develops first-in-class precision medicines targeting previously undruggable proteins in oncology and other serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoveryprecision medicinesmall moleculecovalent drug discoveryAI drug discoverycomputational chemistryoncology therapeuticsundruggable targetschemical proteomicsbiotechin silico drug designpharma partnershipAI-native biotechdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antares Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Antares Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Antares Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Corporate Funding	Jun 24, 2026
Series A	Jun 10, 2025

View all Funding Rounds

Antares Therapeutics Investors

Notable investors and investment history

Antares Therapeutics investors
Investor	Rounds
Omega Funds	Series A
Cormorant Asset Management	Series A
Vida Ventures	Series A
Abingworth	Series A
BVF Partners L.P.	Series A
Atlas Venture	Series A
Willett Advisors	Series A

View all Investors

Antares Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Antares Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antares Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Employee Range104

Year Founded2025

Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.